Abstract
Cyanovirin-N (CV-N) is a two-domain, cyanobacterial protein that inhibits human immunodeficiency virus (HIV) at nanomolar concentrations by binding to high mannose sugars on the HIV envelope glycoprotein gp120. The wild type protein can exist as a monomer or a domain-swapped dimer with the monomer and dimer containing two or four sugar binding sites, respectively, one on each domain. Here we demonstrate that monomeric, single binding site mutants are completely inactive and that a single site, whether located on domain A or B, is insufficient to impart the antiviral activity. Linking inactive, monomeric proteins in a head-to-head fashion by an intermolecular disulfide bond or by creating an exclusively domain-swapped dimer via a hinge residue deletion restored antiviral activity to levels similar to that of wild type CV-N. These findings demonstrate unequivocally that multisite binding by CV-N type lectins is necessary for viral inhibition.
Highlights
Cyanovirin-N (CV-N) is a two-domain, cyanobacterial protein that inhibits human immunodeficiency virus (HIV) at nanomolar concentrations by binding to high mannose sugars on the HIV envelope glycoprotein gp120
CV-N exerts its antiviral activity by binding to high mannose sugars on the viral envelope glycoproteins and prevents virus entry into the cell [5, 6]
We show that: (i) a single sugar-protein contact is insufficient for functional high affinity interaction; (ii) the involvement of at least two binding sites is critical for anti-HIV activity of CV-N; (iii) a non-native, disulfide-linked dimer of two single site, inactive monomers exhibits activity approaching that of wild type CV-N; and (iv) enforcing domain swapping of an inactive, single site mutant restores antiHIV activity
Summary
Cyanovirin-N (CV-N) is a two-domain, cyanobacterial protein that inhibits human immunodeficiency virus (HIV) at nanomolar concentrations by binding to high mannose sugars on the HIV envelope glycoprotein gp120. The wild type protein can exist as a monomer or a domain-swapped dimer with the monomer and dimer containing two or four sugar binding sites, respectively, one on each domain.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have